Guideline for the treatment of chronic lymphocytic leukaemia: a British Society for Haematology guideline.
Authors
Schuh, AParry-Jones, N
Appleby, N
Bloor, Adrian
Dearden, C
Fegan, C
Follows, G
Fox, C
Iyengar, S
Kennedy, B
McCarthy, H
Parry, H
Patten, P
Pettitt, A
Ringshausen, I
Walewska, R
Hillmen, P
Affiliation
NIHR BRC Oxford Molecular Diagnostic Centre, Oxford University Hospitals NHS Trust and Department of Oncology, University of Oxford, John Radcliffe Hospital, OxfordIssue Date
2018-07-15
Metadata
Show full item recordCitation
Guideline for the treatment of chronic lymphocytic leukaemia: a British Society for Haematology guideline. 2018, Br J HaematolJournal
British Journal of HaematologyDOI
10.1111/bjh.15460PubMed ID
30009455Type
ArticleLanguage
enISSN
1365-2141ae974a485f413a2113503eed53cd6c53
10.1111/bjh.15460
Scopus Count
Collections
Related articles
- Guidelines on the diagnosis and management of chronic lymphocytic leukaemia.
- Authors: Oscier D, Fegan C, Hillmen P, Illidge T, Johnson S, Maguire P, Matutes E, Milligan D, Guidelines Working Group of the UK CLL Forum. British Committee for Standards in Haematology
- Issue date: 2004 May
- Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment.
- Authors: Hyde C, Wake B, Bryan S, Barton P, Fry-Smith A, Davenport C, Song F
- Issue date: 2002
- Targeted therapy for chronic lymphocytic leukemia: a glimpse into the future.
- Authors: Hillmen P
- Issue date: 2012 Feb 10
- The use of ibrutinib in chronic lymphocytic leukemia.
- Authors: Damon LE
- Issue date: 2016 Mar
- Treatment for relapsed or refractory chronic lymphocytic leukaemia: an ongoing challenge.
- Authors: Strati P
- Issue date: 2017 Mar